首页> 外文OA文献 >Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
【2h】

Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores

机译:用抗凝剂预测上消化道出血和颅内出血的风险:队列研究得出和验证QBleed评分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To develop and validate risk algorithms (QBleed) for estimating the absolute risk of upper gastrointestinal and intracranial bleed for patients with and without anticoagulation aged 21-99 years in primary care.ududDesign: Open cohort study using routinely collected data from general practice linked to hospital episode statistics data and mortality data during the five year study period between 1 January 2008 and 1 October 2013.ududSetting: 565 general practices in England contributing to the national QResearch database to develop the algorithm and 188 different QResearch practices to validate the algorithm. All 753 general practices had data linked to hospital episode statistics and mortality data at individual patient level.ududEndpoint: Gastrointestinal bleed and intracranial bleed recorded on either the linked mortality data or the linked hospital records.ududParticipants: We studied 4.4 million patients in the derivation cohort with 16.4 million person years of follow-up. During follow-up, 21 641 patients had an incident upper gastrointestinal bleed and 9040 had an intracranial bleed. For the validation cohort, we identified 1.4 million patients contributing over 4.9 million person years of follow-up. During follow-up, 6600 patients had an incident gastrointestinal bleed and 2820 had an intracranial bleed. We excluded patients without a valid Townsend score for deprivation and those prescribed anticoagulants in the 180 days before study entry.ududRisk factors: Candidate variables recorded on the general practice computer system before entry to the cohort, including personal variables (age, sex, Townsend deprivation score, ethnicity), lifestyle variables (smoking, alcohol intake), chronic diseases, prescribed drugs, clinical values (body mass index, systolic blood pressure), and laboratory test results (haemoglobin, platelets). We also included previous bleed recorded before entry to the study.ududResults: The final QBleed algorithms incorporated 21 variables. When applied to the validation cohort, the algorithms in women explained 40% of the variation for upper gastrointestinal bleed and 58% for intracranial bleed. The corresponding D statistics were 1.67 and 2.42. The receiver operating curve statistic values were 0.77 and 0.86. The sensitivity values for the top 10th of men and women at highest risk were 38% and 51%, respectively. There were similar results for men.ududConclusion: The QBleed algorithms provided valid measures of absolute risk of gastrointestinal and intracranial bleed in patients with and without anticoagulation as shown by the performance of the algorithms in a separate validation cohort. Further research is needed to evaluate the clinical outcomes and the cost effectiveness of using these algorithms in primary care.
机译:目的:开发和验证风险算法(QBleed),以评估21-99岁在初级保健中有和没有抗凝治疗的患者上消化道和颅内出血的绝对风险。 ud ud设计:采用常规收集的数据进行开放队列研究与2008年1月1日至2013年10月1日这五年研究期间的医院发作统计数据和死亡率数据相关联的通用做法。 ud ud设置:英格兰的565个通用做法有助于国家QResearch数据库开发算法和188种不同的QResearch验证算法的实践。所有753种常规做法的数据都与各个患者级别的医院发作统计数据和死亡率数据相关。 ud ud终点:在相关的死亡率数据或相关的医院记录中记录了胃肠道出血和颅内出血。 ud ud参与者:我们研究了4.4派生队列中有100万患者接受了1640万个人年的随访。在随访期间,有21 641例患者发生了上消化道出血,而9040例发生了颅内出血。对于验证队列,我们​​确定了140万患者,随访时间超过490万人。在随访期间,有6600例患者发生了胃肠道出血,而2820例发生了颅内出血。我们排除了没有有效Townsend评分剥夺的患者和在研究进入前180天内处方抗凝药的患者。 ud ud风险因素:进入队列之前,在通用计算机系统上记录的候选变量,包括个人变量(年龄,性别) ,汤森剥夺分数,种族),生活方式变量(吸烟,饮酒),慢性疾病,处方药,临床值(体重指数,收缩压)和实验室检查结果(血红蛋白,血小板)。 ud ud结果:最终的QBleed算法包含21个变量。当应用于验证队列时,女性中的算法解释了上消化道出血的40%和颅内出血的58%。相应的D统计分别是1.67和2.42。接收器工作曲线统计值分别为0.77和0.86。风险最高的前十名男性和女性的敏感度值分别为38%和51%。结论:QBleed算法提供了有效的量度,用于有和没有抗凝治疗的患者胃肠道和颅内出血的绝对风险,如在单独的验证队列中的算法所示。需要进一步的研究来评估临床结果以及在初级保健中使用这些算法的成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号